View More View Less
  • 1 Országos Gyermekegészségügyi Intézet Ifjúsági és Családtervezési Osztály Budapest Bolgárkerék u. 3. 1148
Restricted access

A perikoncepcionális gondozás 3 hónappal a tervezett terhességet megelőzően kezdődik és a 3. terhességi hónapig tart. A célja, hogy a veleszületett rendellenességek és a koraszülés kockázatát csökkentse. Jelenleg a fejlett országokban a csecsemőhalandóság 20–25%-áért a veleszületett rendellenességek felelősek és a vezető halálokok közé tartoznak. Jellemző rájuk, hogy defekt állapotot képviselnek, s a teljes gyógyulás ritkán érhető el. Ezért az elsődleges megelőzés jelentheti az egészségügyi ellátás számára az egyetlen optimális megoldást. Az elmúlt 25 évben számos vizsgálat igazolta a perikoncepcionális időszakban alkalmazott folsavszupplementáció hatékonyságát a veleszületett rendellenességek – főleg az idegcső-záródási rendellenesség – terén. A családtervezési szolgáltatás Magyarországon 1984 óta működik. Ez a modell optimális lehetőség a perikoncepcionális folsav/multivitamin szupplementáció bevezetésére, így eredményes eljárást biztosít veleszületett rendellenességek megelőzésére. Orv. Hetil, 45, 1858–1862.

  • Czeizel, A. E.: Ten years of experience in the periconceptional care. Eur. J. Obstet. Gyn. Reprod. Biol., 1999, 89 , 43–49.

    Czeizel A. E. , 'Ten years of experience in the periconceptional care ' (1999 ) 89 Eur. J. Obstet. Gyn. Reprod. Biol. : 43 -49.

    • Search Google Scholar
  • Smithells, R. W., Sheppard, S., Schorah, C. J. és mtsai: Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet, 1980, 1 , 339–340.

    Schorah C. J. , 'Possible prevention of neural-tube defects by periconceptional vitamin supplementation ' (1980 ) 1 Lancet : 339 -340.

    • Search Google Scholar
  • Smithells, R. W., Sheppard, S., Wild, J. és mtsa: Prevention of neural-tube defect recurrences in Yorkshire: final report. Lancet, 1989, 2 , 498–499.

    Wild J. , 'Prevention of neural-tube defect recurrences in Yorkshire: final report ' (1989 ) 2 Lancet : 498 -499.

    • Search Google Scholar
  • MRC Vitamin Research Group: Prevention of neural-tube defects: results of the Medical Research Council vitamin study. Lancet, 1991, 338 , 131–137.

    'Prevention of neural-tube defects: results of the Medical Research Council vitamin study ' (1991 ) 338 Lancet : 131 -137.

    • Search Google Scholar
  • Butterworth, C. E., Tamura, T.: Folic acid and toxicity: a brief review. Am. J. Clin. Nutr., 1989, 50 , 353–358.

    Tamura T. , 'Folic acid and toxicity: a brief review ' (1989 ) 50 Am. J. Clin. Nutr. : 353 -358.

    • Search Google Scholar
  • Czeizel, A. E., Dudás, I.: Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med., 1992, 327 , 1832–1835.

    Dudás I. , 'Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation ' (1992 ) 327 N. Engl. J. Med. : 1832 -1835.

    • Search Google Scholar
  • Berry, R. J., Li, Z., Erickson, J. D. és mtsai: Prevention of neural-tube defects with folic acid in China. N. Engl. J. Med., 1999, 341 , 1485–1490.

    Erickson J. D. , 'Prevention of neural-tube defects with folic acid in China ' (1999 ) 341 N. Engl. J. Med. : 1485 -1490.

    • Search Google Scholar
  • Botto, L. D., Khoury, M. J., Mulinare, J. és mtsa: Periconceptional multivitamin use and the occurrence of conotruncal heart defects. Pediatrics, 1996, 98 , 911–917.

    Mulinare J. , 'Periconceptional multivitamin use and the occurrence of conotruncal heart defects ' (1996 ) 98 Pediatrics : 911 -917.

    • Search Google Scholar
  • Botto, L. D., Plney, R. S., Erickson, J. D.: Vitamin supplements and the risk for congenital anomalities other than neural tube defects. Am. J. Med. Genet., 2004, 125 , 12–21.

    Erickson J. D. , 'Vitamin supplements and the risk for congenital anomalities other than neural tube defects ' (2004 ) 125 Am. J. Med. Genet. : 12 -21.

    • Search Google Scholar
  • Czeizel, A. E.: Prevention of congenital abnormalities by periconceptional multivitamin supplementation. Br. Med. J., 1993, 306 , 1645–1648.

    Czeizel A. E. , 'Prevention of congenital abnormalities by periconceptional multivitamin supplementation ' (1993 ) 306 Br. Med. J. : 1645 -1648.

    • Search Google Scholar
  • Czeizel, A. E.: Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am. J. Med. Genet., 1996, 62 , 179–183.

    Czeizel A. E. , 'Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation ' (1996 ) 62 Am. J. Med. Genet. : 179 -183.

    • Search Google Scholar
  • Daly, S., Mills, J. L., Molloy, A. M. és mtsai: Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet, 1997, 350 , 1666–1669.

    Molloy A. M. , 'Minimum effective dose of folic acid for food fortification to prevent neural-tube defects ' (1997 ) 350 Lancet : 1666 -1669.

    • Search Google Scholar
  • Kapusa, L., Haagmans, M. L. M., Steegers, E. A. P. és mtsai: Congenital heart defects and derangement of homocysteine metabolism. J. Pediatr., 1999, 135 , 773–774.

    Steegers E. A. P. , 'Congenital heart defects and derangement of homocysteine metabolism ' (1999 ) 135 J. Pediatr. : 773 -774.

    • Search Google Scholar
  • Li, D-K., Daling, J. R., Mueller, B. A. és mtsai: Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalities. Epidemiology, 1995, 6 , 212–218.

    Mueller B. A. , 'Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalities ' (1995 ) 6 Epidemiology : 212 -218.

    • Search Google Scholar
  • Czeizel, A. E.: Prevention of oral clefs through the use of folic acid and multivitamin supplements: evidence and gap. In: Cleft Lip and Palate. From Origin to Treatment. Ed: Wyszynski, D. F. Oxford University Press, New York, 2002, 443–457.

    Czeizel A. E. , '', in Cleft Lip and Palate. From Origin to Treatment , (2002 ) -.

  • Czeizel, A. E., Tímár, L., Sárközi, A.: Dose-dependent effect of folic acid on the prevention of orofacial clefs. Pediatrics, 1999, 104 , e66.

    Sárközi A. , 'Dose-dependent effect of folic acid on the prevention of orofacial clefs ' (1999 ) 104 Pediatrics : e66 -.

    • Search Google Scholar
  • Tolarova, M.: Periconceptional supplementation with vitamins and folic acid to prevent recurrence of cleft lip. Lancet, 1982, 2 , 217.

    Tolarova M. , 'Periconceptional supplementation with vitamins and folic acid to prevent recurrence of cleft lip ' (1982 ) 2 Lancet : 217 -.

    • Search Google Scholar
  • DiPietro, J. A., Novak, M. F. S. X., Costigan, K. A. és mtsai: Maternal psychological distress during pregnancy in relation to child development at age two. Child Dev., 2006, 77 , 573–587.

    Costigan K. A. , 'Maternal psychological distress during pregnancy in relation to child development at age two ' (2006 ) 77 Child Dev. : 573 -587.

    • Search Google Scholar
  • Helland, I. B., Smith, L., Saarem, K. és mtsai: Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics, 2003, 111 , 39–44.

    Saarem K. , 'Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age ' (2003 ) 111 Pediatrics : 39 -44.

    • Search Google Scholar
  • Nurk, E., Tell, G. S., Refsum, H. és mtsai: Associations between maternal methylenetetrahydrofolate reductase polymorphisms and adverse outcomes of pregnancy: The hordaland homocysteine study. Am. J. Med., 2004, 117 , 26–31.

    Refsum H. , 'Associations between maternal methylenetetrahydrofolate reductase polymorphisms and adverse outcomes of pregnancy: The hordaland homocysteine study ' (2004 ) 117 Am. J. Med. : 26 -31.

    • Search Google Scholar
  • SanGiovanni, J. P., Berkey, C. S., Dwyer, J. T. és mtsa: Dietary essential fatty acids, long-chain polyunsaturated fatty acids, and visual resolution acuity in healthy fullterm infants: a systematic review. Early Hum. Dev., 2000, 57 , 165–188.

    Dwyer J. T. , 'Dietary essential fatty acids, long-chain polyunsaturated fatty acids, and visual resolution acuity in healthy fullterm infants: a systematic review ' (2000 ) 57 Early Hum. Dev. : 165 -188.

    • Search Google Scholar
  • Tarusco, D.: Folic acid: from research to public health practice. Rapporti ISTISAN, Roma, 2004.

    Tarusco D. , '', in Folic acid: from research to public health practice , (2004 ) -.

  • Food Safety Authority of Ireland: Report of the Committee on Folic Acid Food Fortification. 2006.

  • Akoglu, B., Schrott, M., Bolouri, H. és mtsai: The folic acid metabolite L-5-methyltetrahydrofolate effectively reduces total serum homocysteine level in orthotopic liver transplant recipients: a double-blind placebo-controlled study. Eur. J. Clin. Nutr., 2008, 62 , 796–801.

    Bolouri H. , 'The folic acid metabolite L-5-methyltetrahydrofolate effectively reduces total serum homocysteine level in orthotopic liver transplant recipients: a double-blind placebo-controlled study ' (2008 ) 62 Eur. J. Clin. Nutr. : 796 -801.

    • Search Google Scholar
  • Van Beynum, I. M., Kapusa, L., den Heijer, M. és mtsai: Maternal MTHFR 677C T is a risk factor for congenital heart defect: effect modification by periconceptional folate supplementation. Eur. Heart J., 2006, 27 , 981–987.

    Heijer M. , 'Maternal MTHFR 677C T is a risk factor for congenital heart defect: effect modification by periconceptional folate supplementation ' (2006 ) 27 Eur. Heart J. : 981 -987.

    • Search Google Scholar
  • Gueant, J. L., Gueant-Rodriguez, R. M., Anello, G. és mtsai: Genetic determination of folate and vitamin B12 metabolism: a common pathway in neural-tube defects and Down’s syndrome. Clin. Chem. Lab. Med., 2003, 41 , 1473–1477.

    Anello G. , 'Genetic determination of folate and vitamin B12 metabolism: a common pathway in neural-tube defects and Down’s syndrome ' (2003 ) 41 Clin. Chem. Lab. Med. : 1473 -1477.

    • Search Google Scholar
  • Hobbs, C. A., Sherman, S. L., Yi, P. és mtsai: Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down’s syndrome. Am. J. Hum. Genet., 2000, 67 , 623–630.

    Yi P. , 'Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down’s syndrome ' (2000 ) 67 Am. J. Hum. Genet. : 623 -630.

    • Search Google Scholar
  • Vollset, S. E., Refsum, H., Irgens, L. M. és mtsai: Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine Study. Am. J. Clin. Nutr., 2000, 71 , 962–968.

    Irgens L. M. , 'Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine Study ' (2000 ) 71 Am. J. Clin. Nutr. : 962 -968.

    • Search Google Scholar
  • Wald, N. J., Law, M. R., Morris, J. K. és mtsa: Quantifying the effect of folic acid. Lancet, 2001, 358 , 2069–2073.

    Morris J. K. , 'Quantifying the effect of folic acid ' (2001 ) 358 Lancet : 2069 -2073.

  • Houghton, L. A., Sherwood, K. L., Pawlosky, R. és mtsai: [6S]-5-methyltetrahydrofolate is at least as effective as folic acid in preventing a decline in blood folate concentrations during lactation. Am. J. Clin. Nutr., 2006, 83 , 842–850.

    Pawlosky R. , '[6S]-5-methyltetrahydrofolate is at least as effective as folic acid in preventing a decline in blood folate concentrations during lactation ' (2006 ) 83 Am. J. Clin. Nutr. : 842 -850.

    • Search Google Scholar
  • Koletzko, B., Cetin, I., Brenna, J. T.: Dietary fat intakes for pregnant and lactating women. Br. J. Nutr., 2007, 98 , 873–877.

    Brenna J. T. , 'Dietary fat intakes for pregnant and lactating women ' (2007 ) 98 Br. J. Nutr. : 873 -877.

    • Search Google Scholar
  • Centers for Disease Control and Prevention: CDC Grand Rounds: Additional opportunities to prevent neural tube defects with folic acid fortification. Weekly, 2010, 59 , 980–984.

    'CDC Grand Rounds: Additional opportunities to prevent neural tube defects with folic acid fortification ' (2010 ) 59 Weekly : 980 -984.

    • Search Google Scholar
  • Venn, B. J., Green, T. J., Moser, R. és mtsa: Comparison of the effect of low-dose supplementation with L-5-methyltetrahydrofolate or folic acid on plasma homocysteine: a randomized placebo-controlled study. Am. J. Clin. Nutr., 2003, 77 , 658–662.

    Moser R. , 'Comparison of the effect of low-dose supplementation with L-5-methyltetrahydrofolate or folic acid on plasma homocysteine: a randomized placebo-controlled study ' (2003 ) 77 Am. J. Clin. Nutr. : 658 -662.

    • Search Google Scholar
  • Nelen, W. L. D. M., Blom, H. J., Steegers, E. A. P. és mtsai: Homocysteine and folate levels as risk factors for recurrent early pregnancy loss. Obstet. Gynecol., 2000, 95 , 519–524.

    Steegers E. A. P. , 'Homocysteine and folate levels as risk factors for recurrent early pregnancy loss ' (2000 ) 95 Obstet. Gynecol. : 519 -524.

    • Search Google Scholar
  • Botto, L. D., Yang, Q.: 5, 10-methylenetetrahydrofolate reductase gene variants and congenital anomalies: A HuGE Review. Am. J. Epidemiol., 2000, 151 , 862–877.

    Yang Q. , '5, 10-methylenetetrahydrofolate reductase gene variants and congenital anomalies: A HuGE Review ' (2000 ) 151 Am. J. Epidemiol. : 862 -877.

    • Search Google Scholar

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jan 2021 5 0 0
Feb 2021 8 0 0
Mar 2021 8 0 0
Apr 2021 12 0 0
May 2021 12 1 1
Jun 2021 1 0 0
Jul 2021 0 0 0